<DOC>
	<DOCNO>NCT02165657</DOCNO>
	<brief_summary>The overall aim study determine whether UVB excimer laser treatment psoriasis affect serum inflammatory marker , assess hyperpigmentation erythema excimer laser treatment . The investigator hypothesize treatment psoriasis UVB deliver via 308 nm excimer laser decrease level serum inflammatory marker . The investigator hypothesize treatment decrease plaque erythema result minimal hyperpigmentation .</brief_summary>
	<brief_title>Excimer Laser , Serum Markers &amp; Psoriasis</brief_title>
	<detailed_description>Subjects undergo Excimer treatment twice week reach PASI 75 improvement , reach maximum 20 total treatment . A blood draw ass serum inflammatory marker perform screen visit final visit . Chromameter assessment , photograph , PASI PGA ( Physician Global Assessment ) perform throughout study monitor psoriasis improvement , hyperpigmentation erythema .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Age 18 year old Male female diagnosis psoriasis Psoriasis involvement 515 % BSA Has systemic psoriasis therapy ( e.g . retinoids , methotrexate , biologic agent , etc ) least 4 week Has topical therapy ( e.g . calcipotriene , topical steroid ) least 2 week Fitzpatrick Skin Types IVI Active history photosensitivity ( e.g . xeroderma pigmentosum , lupus erythematosus , porphyria , severe polymorphous light eruption , solar urticaria ) Any suspicion psoriasis photosensitive variant . Any medical condition could aggravate may cause extreme discomfort study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Excimer laser</keyword>
	<keyword>UVB</keyword>
	<keyword>Psoriasis</keyword>
</DOC>